Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7263)
All Articles published online
|
Publishing Process of This Article
|
Sep 18, 2016 (publication date) through Mar 28, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Noll ATR, Cramer T, Olde Damink SWM, Schaap FG. Cholangiocarcinoma, gone without the Wnt? World J Hepatol 2016; 8(26): 1093-1096 [PMID: 27660676 DOI: 10.4254/wjh.v8.i26.1093] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i26/1093.htm |
| Number | Citing Articles |
| 1 |
Shuai He, Shilei Tang. WNT/β-catenin signaling in the development of liver cancers. Biomedicine & Pharmacotherapy 2020; 132: 110851 doi: 10.1016/j.biopha.2020.110851
|
| 2 |
Bo-Nan Xu, Cheng-Hong Ding, Yi-Long Liu, Yuan-Yuan Luo, Juan Deng, Shu-Qing Liu, Meng-Chao Xiao, Nan Jiang, Xin Zhang, Wen-Ping Xu, Wei-Fen Xie. HNF4α inhibits the malignancy of intrahepatic cholangiocarcinoma by suppressing the Wnt signaling pathway. Translational Oncology 2025; 53: 102290 doi: 10.1016/j.tranon.2025.102290
|
| 3 |
Anirudh Nayak, Hannah Streiff, Ivan Gonzalez, Oluwabomi Oluwatomi Adekoya, Itzcoatl Silva, Anitha Kota Shenoy. Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications. Cells 2025; 14(3): 178 doi: 10.3390/cells14030178
|
| 4 |
Nan Wu, Sareh Bayatpour, Phillip B. Hylemon, Sayed O. Aseem, Paul J. Brindley, Huiping Zhou. Gut Microbiome and Bile Acid Interactions. The American Journal of Pathology 2025; 195(3): 397 doi: 10.1016/j.ajpath.2024.11.004
|
| 5 |
Adrian P. Mansini, Estanislao Peixoto, Kristen M. Thelen, Cesar Gaspari, Sujeong Jin, Sergio A. Gradilone. The cholangiocyte primary cilium in health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1245 doi: 10.1016/j.bbadis.2017.06.006
|
| 6 |
Rita Manco, Isabelle A. Leclercq, Laure-Alix Clerbaux. Liver Regeneration: Different Sub-Populations of Parenchymal Cells at Play Choreographed by an Injury-Specific Microenvironment. International Journal of Molecular Sciences 2018; 19(12): 4115 doi: 10.3390/ijms19124115
|
| 7 |
Yongqin Ye, Vincent Chi Hang Lui, Paul Kwong Hang Tam. Pathogenesis of Choledochal Cyst: Insights from Genomics and Transcriptomics. Genes 2022; 13(6): 1030 doi: 10.3390/genes13061030
|
| 8 |
Guo-Feng Zhang, Ling Qiu, Shu-Li Yang, Jia-Cheng Wu, Tong-Jun Liu. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma. Bioscience Reports 2020; 40(3) doi: 10.1042/BSR20193353
|
| 9 |
Norma Pangestu, Piyasiri Chueakwon, Krajang Talabnin, Juthamas Khiaowichit, Chutima Talabnin. RNF43 overexpression attenuates the Wnt/β‑catenin signalling pathway to suppress tumour progression in cholangiocarcinoma. Oncology Letters 2021; 22(6) doi: 10.3892/ol.2021.13107
|
| 10 |
Fei Chen, Jian Sheng, Xiaoping Li, Zhaofeng Gao, Lingyu Hu, Minjie Chen, Jianguo Fei, Zhengwei Song. Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1451474
|